Table 3. Univariate and multivariate Cox regression analysis for OS.
Univariate | Multivariate | |||
Variable | HR (95% CI) | p -Value | HR (95% CI) | p -Value |
Age at diagnosis | 0.99 (0.94–1.03) | 0.69 | ||
Sex | 1.94 (0.55–6.77) | 0.29 | ||
Hyams grade, high vs. low | 3.75 (0.96–14.6) | 0.05 | 22.1 (2.2–218) | 0.008 |
Kadish stage, A-B vs. C-D | 0.22 (0.02–1.80) | 0.16 | ||
Node status, positive vs. negative | 11.7 (2.42–55.5) | 0.002 | 14.7 (1.9–111) | 0.01 |
Chemotherapy, yes vs. no | 12.1 (1.87–76.9) | 0.009 | 0.41 (0.04–3.87) | 0.43 |
Radiation, yes vs. no | .03 (0.0–48.7) | 0.35 | ||
Radiation, IORT vs. EBRT | .85 (0.18–3.9) | 0.83 | ||
Radiation, ENI vs. primary only | .686 (0.2–4.3) | 0.99 | ||
Surgery type, craniotomy vs. endoscopic | 0.56 (0.12–2.59) | 0.46 | ||
Diagnosis era, 1996–2010 vs. 2010–2017 | 0.94 (0.20–4.37) | 0.94 | ||
Univariate and multivariate Cox regression of disease recurrence score | ||||
Univariate | Multivariate | |||
Variable | HR (95% CI) | p | HR (95% CI) | p -Value |
Age at diagnosis | 0.349 (0.07–1.6) | 0.18 | ||
Sex | 1.05 (0.32–3.48) | 0.92 | ||
Hyams grade, high vs. low | 12.5 (1.55–49.3) | 0.01 | 17.0 (1.01–288.4) | 0.049 |
Kadish stage, A-B vs. C-D | 0.75 (0.23–2.5) | 0.64 | ||
Node status, positive vs. negative | 6.06 (1.33–27.7) | 0.02 | 8.3 (0.57–10.5) | 0.16 |
Chemotherapy, yes vs. no | 0.44 (0.04–4.46) | 0.48 | ||
Radiation, yes vs. no | 0.37 (0.04–3.0) | 0.36 | ||
Radiation, IORT vs. EBRT | 1.6 (0.44–6.0) | 0.46 | ||
Radiation, ENI vs. primary only | 0.42 (0.04–3.9) | 0.45 | ||
Surgery type, craniotomy vs. endoscopic | 0.71 (0.19–2.6) | 0.6 | ||
Diagnosis era, 1996–2010 vs. 2010–2017 | 1.8 (0.36–9.4) | 0.44 |
Abbreviations: CI, confidence interval; EBRT, external beam radiation therapy; ENI, elective nodal radiation; HR, hazard ratio; IORT, intraoperative radiation therapy; OS, overall survival.